OpenAlex
PricingAboutJobs
Log inGet started
Work

Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial

HTML

Year: 2015
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet
DOI: 10.1016/s0140-6736(15)60158-1
Authors: G Kees Hovingh, John J P Kastelein, Sander J H van Deventer, Patrick Round, John Ford, Danish Saleheen, Daniel J Rader, H Bryan Brewer, Philip J Barter
Institutions: Amsterdam UMC Location University of Amsterdam, University of Amsterdam, Leiden University Medical Center, Xention (United Kingdom), University of Pennsylvania, MedStar Washington Hospital Center, Washington Hospital, MedStar Health Research Institute, UNSW Sydney
Language: English

Topic: Lipoproteins and Cardiovascular Health
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: cholesterol ester transfer protein inhibitors, LDL cholesterol lowering, HDL cholesterol, statin combination therapy, atorvastatin, rosuvastatin, lipid-lowering therapy, cardiovascular risk, drug safety and tolerability, dose-response relationship
SDG: Good health and well-being

Open Access status: green
OpenAlex ID: W1574102128
FWCI: 21.12
Cites: 18
Cited by: 249
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security